journal article·2026-01

Sustained Activation of Nrf2 Antioxidant Pathway by Flexible Liposome Based on Low Phase Transition Temperature to Delay Skin Aging

Huihui Liu, Yilong Hu, Wanting Ji, Sijie Wang, Ying Zhu, Qing Lin, Xiaoqi Zhao, Huanli Zhou, Xuemeng Guo, Yu Liu, Yingying Shi, Junlei Zhang, Zhenyu Luo, Jiaxin Huang, Hang Yin, Lihua Luo, Jian You

Advanced Healthcare Materials· Volume 15· Issue 3
Publisher page

Abstract

Abstract Intrinsic skin aging and photoaging induce alterations in skin morphology and increase the risk of skin diseases. Reactive oxygen species (ROS) are key contributors to these processes, and nuclear factor erythroid 2‐related factor 2 (Nrf2), a central antioxidant transcription factor, represents a promising therapeutic target for combating oxidative stress. Therefore, activation of Nrf2 is anticipated to alleviate oxidative stress, preserve cellular homeostasis, and restore dermal fibroblast function by upregulating antioxidant enzymes. In this study, the Nrf2 agonist dimethyl fumarate (DMF) is selected as a model drug, and constructed flexible liposome FL@SC by adding anionic surfactants to enhance the skin penetration, and achieved sustained activation of Nrf2 through the controlled release of DMF, while improving the concentration dependence of DMF on cell protection. The results showed that Nrf2 activation ex erted remarkable anti‐aging effects in two skin aging models induced by D‐galactose and UVB. FL@SC significantly enhanced the penetration and retention of DMF in the dermis, thereby inhibiting hallmarks of skin aging, including structural disorganization, flattening of epidermal rete ridges, and collagen degradation. Collectively, this study presents a viable strategy for delaying skin aging by alleviating oxidative stress in dermal fibroblasts via the targeted delivery of Nrf2 agonists using flexible liposomes.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Skin Protection and Aging · Genomics, phytochemicals, and oxidative stress · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Pharmaceutical Sciences Zhejiang University 866 Yuhangtang Road Hangzhou Zhejiang 310058 P. R. China

Zhejiang‐California International Nanosystems Institute Zhejiang University Hangzhou 310058 P. R. China

Hangzhou Institute of Innovative Medicine Zhejiang University Hangzhou Zhejiang 310058 P. R. China

Funding

National Natural Science Foundation of China

References (53)

Show source-provided references
1. 10.3390/nu1001004410.3390/nu10010044 ↗
2. 10.1136/bmjopen-2015-00994110.1136/bmjopen-2015-009941 ↗
3. 10.1016/j.devcel.2020.11.00210.1016/j.devcel.2020.11.002 ↗
4. 10.1016/j.arr.2020.10103610.1016/j.arr.2020.101036 ↗
5. 10.1038/s41586-019-1085-710.1038/s41586-019-1085-7 ↗
6. 10.1038/s43587-025-00901-610.1038/s43587-025-00901-6 ↗
7. 10.1021/acs.est.5b0296710.1021/acs.est.5b02967 ↗
8. 10.1016/j.jid.2020.11.00710.1016/j.jid.2020.11.007 ↗
9. 10.1016/j.cell.2020.02.01210.1016/j.cell.2020.02.012 ↗
10. 10.1038/s41419-020-2649-z10.1038/s41419-020-2649-z ↗
11. 10.1124/jpet.116.23804810.1124/jpet.116.238048 ↗
12. 10.1016/j.jdermsci.2015.01.00910.1016/j.jdermsci.2015.01.009 ↗
13. Xiao Z. · J. Funct. Foods · 2021 · 74 · 2020
14. 10.1016/j.jid.2020.07.01910.1016/j.jid.2020.07.019 ↗
15. 10.1186/s12964-018-0232-310.1186/s12964-018-0232-3 ↗
16. 10.14336/AD.2018.051310.14336/AD.2018.0513 ↗
17. Baird L. · Mol. Cell. Biol. · 2020 · 40
18. 10.1016/j.cell.2016.05.01710.1016/j.cell.2016.05.017 ↗
19. 10.1038/s41467-020-18764-310.1038/s41467-020-18764-3 ↗
20. 10.1111/jdv.1521810.1111/jdv.15218 ↗
21. 10.1038/s41573-018-0008-x10.1038/s41573-018-0008-x ↗
22. 10.3390/antiox907063010.3390/antiox9070630 ↗
23. 10.1186/1742-2094-7-3010.1186/1742-2094-7-30 ↗
24. 10.1182/blood.202000940410.1182/blood.2020009404 ↗
25. 10.1158/0008-5472.CAN-06-239710.1158/0008-5472.CAN-06-2397 ↗
26. 10.4103/2152-7806.12365610.4103/2152-7806.123656 ↗
27. 10.1126/science.adf415410.1126/science.adf4154 ↗
28. 10.1126/science.aan466510.1126/science.aan4665 ↗
29. 10.1177/155932581774445010.1177/1559325817744450 ↗
30. 10.1016/j.actbio.2020.12.00410.1016/j.actbio.2020.12.004 ↗
31. 10.1021/acs.molpharmaceut.2c0058710.1021/acs.molpharmaceut.2c00587 ↗
32. 10.1016/j.jconrel.2022.10.01110.1016/j.jconrel.2022.10.011 ↗
33. 10.1016/j.tiv.2019.03.00610.1016/j.tiv.2019.03.006 ↗
34. 10.1016/j.cell.2017.05.01510.1016/j.cell.2017.05.015 ↗
35. 10.1038/s41556-018-0206-010.1038/s41556-018-0206-0 ↗
36. 10.1089/wound.2014.056110.1089/wound.2014.0561 ↗
37. 10.1155/2020/714565610.1155/2020/7145656 ↗
38. 10.1016/j.cell.2024.09.02110.1016/j.cell.2024.09.021 ↗
39. 10.1038/ncomms1162410.1038/ncomms11624 ↗
40. 10.1371/journal.pone.015380610.1371/journal.pone.0153806 ↗
41. Nguyen H. P. · Skin Ther. Lett. · 2015 · 20 · 1
42. 10.1007/s11357-011-9339-910.1007/s11357-011-9339-9 ↗
43. 10.1016/j.biopha.2016.12.01110.1016/j.biopha.2016.12.011 ↗
44. 10.1016/j.bbr.2015.12.04110.1016/j.bbr.2015.12.041 ↗
45. 10.1111/jfbc.1442510.1111/jfbc.14425 ↗
46. 10.1016/j.lfs.2019.11659510.1016/j.lfs.2019.116595 ↗
47. 10.1016/S0378-5173(99)00441-X10.1016/S0378-5173(99)00441-X ↗
48. 10.1016/j.cej.2022.13955310.1016/j.cej.2022.139553 ↗
49. 10.1016/j.exger.2014.03.00210.1016/j.exger.2014.03.002 ↗
50. 10.1016/j.jaad.2019.03.08110.1016/j.jaad.2019.03.081 ↗
51. Wang J. · Bioact. Mater. · 2021 · 11 · 154
52. 10.1172/jci.insight.15634410.1172/jci.insight.156344 ↗
53. 10.1111/j.1365-2133.2007.07867.x10.1111/j.1365-2133.2007.07867.x ↗